Characterization of a novel 21-kb deletion, CFTRdele2,3(21 kb), in the CFTR gene:: a cystic fibrosis mutation of Slavic origin common in Central and East Europe

被引:110
作者
Dörk, T
Macek, M
Mekus, F
Tümmler, B
Tzountzouris, J
Casals, T
Krebsová, A
Koudová, M
Sakmaryová, I
Macek, M
Vávrová, V
Zemková, D
Ginter, E
Petrova, NV
Ivaschenko, T
Baranov, V
Witt, M
Pogorzelski, A
Bal, J
Zékanowsky, C
Wagner, K
Stuhrmann, M
Bauer, I
Seydewitz, HH
Neumann, T
Jakubiczka, S
Kraus, C
Thamm, B
Nechiporenko, M
Livshits, L
Mosse, N
Tsukerman, G
Kadási, L
Ravnik-Glavac, M
Glavac, D
Komel, R
Vouk, K
Kucinskas, V
Krumina, A
Teder, M
Kocheva, S
Efremov, GD
Onay, T
Kirdar, B
Malone, G
Schwarz, M
Zhou, ZQ
Friedman, KJ
Carles, S
Claustres, M
机构
[1] Hannover Med Sch, Inst Human Genet, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Pediat Pulmonol, D-30625 Hannover, Germany
[3] Charles Univ Prague, Inst Biol & Med Genet, Prague, Czech Republic
[4] Hosp Sick Children, Dept Genet & Genom Biol, Toronto, ON M5G 1X8, Canada
[5] Hosp DYR, Genet Dept IRO, Barcelona, Spain
[6] Russian Acad Sci, Med Genet Res Ctr, Moscow, Russia
[7] Inst Obstet & Gynecol, St Petersburg, Russia
[8] Polish Acad Sci, Inst Human Genet, PL-60479 Poznan, Poland
[9] Inst TB & Lung Dis, Rabka, Poland
[10] Natl Res Inst Mother & Child, Warsaw, Poland
[11] Dept Human Genet, Graz, Austria
[12] Dept Med Genet, Rostock, Germany
[13] Childrens Hosp, Univ Clin, Freiburg, Germany
[14] Univ Munster, Inst Human Genet, D-4400 Munster, Germany
[15] Otto Von Guericke Univ, Inst Human Genet, Magdeburg, Germany
[16] Univ Erlangen Nurnberg, Inst Human Genet, D-8520 Erlangen, Germany
[17] Inst Human Genet, Leipzig, Germany
[18] Ukrainian Acad Sci, Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine
[19] Inst Hereditary Disorders, Minsk, BELARUS
[20] Comenius Univ, Inst Mol Physiol & Genet, Bratislava, Slovakia
[21] Univ Ljubljana, Fac Med, Inst Pathol, Mol Genet Lab, Ljubljana, Slovenia
[22] Med Ctr Mol Biol, Ljubljana, Slovenia
[23] Univ Hosp Vilnuis, Ctr Human Genet, Vilnius, Lithuania
[24] Med Acad, Dept Med Biol & Genet, Riga, Latvia
[25] Univ Tartu, Ctr Med Genet, EE-50090 Tartu, Estonia
[26] Macedonian Acad Sci & Arts, Skopje, North Macedonia
[27] Bogazici Univ, Dept Chem Engn & Med Biol & Genet, Bebek, Turkey
[28] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England
[29] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA
[30] Ctr Hosp Univ, Montpellier, France
[31] Hop Debrousse, Lyon, France
[32] Ctr Transfus Consanguine, Brest, France
[33] Univ Athens, Dept Pediat 1, Athens, Greece
[34] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium
[35] Univ Verona, DMIBG, Sect Biol & Genet, I-37100 Verona, Italy
[36] Tor Vergata Univ, Catedra Genet Umana, Rome, Italy
[37] CSS Mendel, Rome, Italy
[38] Univ Hosp Obstet & Gynecol, Lab Mol Pathol, Sofia, Bulgaria
[39] Inst Mol Genet & Genet Engn, Belgrade, Yugoslavia
[40] Univ Sch Med, Clin Inst Lab Diag, Zagreb, Croatia
[41] Sahlgrens Univ Hosp, E Gothenborg Univ, Dept Clin Genet & Pediat, S-41345 Gothenburg, Sweden
[42] IIBCE, Montevideo, Uruguay
[43] Alberta Childrens Prov Gen Hosp, Calgary, AB T2T 5C7, Canada
[44] St Pauls Hosp, CF Adult Clin, Vancouver, BC V6Z 1Y6, Canada
[45] IWK Grace Hlth Ctr, Halifax, NS, Canada
[46] St Michaels Hosp, CF Adult Clin, Toronto, ON M5B 1W8, Canada
关键词
D O I
10.1007/s004390000246
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
We report a large genomic deletion of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, viz.. a deletion that is frequently observed in Central and Eastern Europe. The mutation, termed CFTRdele2.3(21 kb), deletes 21,080 bp spanning introns 1-3 of the CFTR gene. Transcript analyses have revealed that this deletion results in the loss of exons 2 and 3 in epithelial CFTR mRNA, thereby producing a premature termination signal within exon 4. In order to develop a simple polymerase chain reaction assay for this allele, we defined the end-points of the deletion at the DNA sequence level. We next screened for this mutation in a representative set of European and European-derived populations. Some 197 CF patients, including seven homozygotes, bearing this mutation have been identified during the course of our study. Clinical evaluation of CFTRdele2.3(21 kb) homozygotes and a comparison of compound heterozygotes for Delta F508/CFTRdele2,3(21 kb) with pairwise-matched Delta F508 homozygotes indicate that this deletion represents a severe mutation associated with pancreatic insufficiency and early age at diagnosis. Current data show that the mutation is particularly common in Czech (6.4% of all CF chromosomes), Russian (5.2%), Belorussian (3.3%). Austrian (2.6%), German (1.5%), Polish (1.5%), Slovenian (1.5%), Ukrainian (1.2%), and Slovak patients (1.1%). It has also been found in Lithuania, Latvia, Macedonia and Greece and has sporadically been observed in Canada, USA, France, Spain, Turkey, and UK, but not in CF patients from Bulgaria, Croatia, Romania or Serbia. Haplotype analysis has identified the same extragenic CF-haplotype: XV-2c/KM. 19 "A" and the same infrequent intragenic microsatellite haplotype 16-33-13 (IVS8CA-IVS17bTA-IVSI7bCA) in all examined CFTRdele2,3(21 kb) chromosomes, suggesting a common origin for this deletion. We conclude that the 21-kb deletion is a frequent and severe CF mutation in populations of Eastern- and Western-Slavic descent.
引用
收藏
页码:259 / 268
页数:10
相关论文
共 51 条
[1]   Palindrome resolution and recombination in the mammalian germ line [J].
Akgun, E ;
Zahn, J ;
Baumes, S ;
Brown, G ;
Liang, F ;
Romanienko, PJ ;
Lewis, S ;
Jasin, M .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (09) :5559-5570
[2]   Cystic fibrosis mutations and associated haplotypes in Bulgaria - A comparative population genetic study [J].
Angelicheva, D ;
Calafell, F ;
Savov, A ;
Jordanova, A ;
Kufardjieva, A ;
Galeva, I ;
Nedkova, V ;
Ivanova, T ;
Yankova, P ;
Konstantinova, D ;
Genev, E ;
Kalaydjieva, L .
HUMAN GENETICS, 1997, 99 (04) :513-520
[3]  
BONIZZATO A, 1995, HUM GENET, V95, P397
[4]  
BOUZEK J, 1982, PRAEHISTORICA, V9
[5]   ASSOCIATION OF CROSSOVER POINTS WITH TOPOISOMERASE-I CLEAVAGE SITES - A MODEL FOR NONHOMOLOGOUS RECOMBINATION [J].
BULLOCK, P ;
CHAMPOUX, JJ ;
BOTCHAN, M .
SCIENCE, 1985, 230 (4728) :954-958
[6]   ALTERNATE TRANSLATION INITIATION CODONS CAN CREATE FUNCTIONAL FORMS OF CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR [J].
CARROLL, TP ;
MORALES, MM ;
FULMER, SB ;
ALLEN, SS ;
FLOTTE, TR ;
CUTTING, GR ;
GUGGINO, WB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) :11941-11946
[7]   High heterogeneity for cystic fibrosis in Spanish families:: 75 mutations account for 90% of chromosomes [J].
Casals, T ;
Ramos, MD ;
Giménez, J ;
Larriba, S ;
Nunes, V ;
Estivill, X .
HUMAN GENETICS, 1997, 101 (03) :365-370
[8]   Removal of multiple arginine-framed trafficking signals overcomes misprocessing of ΔF508 CFTR present in most patients with cystic fibrosis [J].
Chang, XB ;
Cui, LY ;
Hou, YX ;
Jensen, TJ ;
Aleksandrov, AA ;
Mengos, A ;
Riordan, JR .
MOLECULAR CELL, 1999, 4 (01) :137-142
[9]  
CHEVALIERPORST F, 1998, HUM MUTAT S, V1, P291
[10]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159